Cellink Inkredible+
UNICAEN: New Bioprinted Tumor Models Help Researchers in France Study Its Biology
Studying cancer biology is among the top priorities for researchers around the world. From consortiums to universities, pharma companies, newcomers in the drug development industry, and research institutions, current research…
New Method: Immersion Bioprinting of Tumor Organoids Will Increase the Throughput of 3D Drug Screening
Drug testing and screening for cancer drug discovery can take years and the 2D cell cultures and animal models used to estimate their efficacy before reaching human trials are often…
CELLINK in France: Expanding Their Portfolio in 2020
Seeking to strengthen their presence in Europe, 3D bioprinter provider and pioneer bioink company CELLINK, opened their new offices in Lyon, France, last October. Begining new partnerships and collaborations with…
Interview: BIOLIFE4D is The First US Company to Bioprint a Mini-Heart (for Cardiotoxicity Testing)
After quite a few teaser pictures on their social media platforms since August, BIOLIFE4D finally announced one of the biggest milestones for the company: they successfully 3D printed a tiny…
